1. Mitochondrial transplantation ameliorates ischemia/reperfusion-induced kidney injury in rat.
- Author
-
Jabbari H, Roushandeh AM, Rostami MK, Razavi-Toosi MT, Shokrgozar MA, Jahanian-Najafabadi A, Kuwahara Y, and Roudkenar MH
- Subjects
- Acute Kidney Injury pathology, Acute Kidney Injury physiopathology, Acute Kidney Injury surgery, Animals, Apoptosis, Cell Fractionation methods, Cell Survival physiology, Disease Models, Animal, Epithelial Cells metabolism, Epithelial Cells pathology, Humans, Kidney Function Tests, Kidney Tubules, Proximal pathology, Kidney Tubules, Proximal physiopathology, Kidney Tubules, Proximal surgery, Male, Mitochondria physiology, Muscle Cells cytology, Muscle, Skeletal chemistry, Muscle, Skeletal cytology, Primary Cell Culture, Rats, Rats, Wistar, Renal Artery, Reperfusion Injury pathology, Reperfusion Injury physiopathology, Reperfusion Injury surgery, Acute Kidney Injury therapy, Mitochondria transplantation, Muscle Cells chemistry, Recovery of Function physiology, Reperfusion Injury prevention & control
- Abstract
No real therapeutic modality is currently available for Acute kidney injury (AKI) and if any, they are mainly supportive in nature. Therefore, developing a new therapeutic strategy is crucial. Mitochondrial dysfunction proved to be a key contributor to renal tubular cell death during AKI. Thus, replacement or augmentation of damaged mitochondria could be a proper target in AKI treatment. Here, in an animal model of AKI, we auto-transplanted normal mitochondria isolated from healthy muscle cells to injured kidney cells through injection to renal artery. The mitochondria transplantation prevented renal tubular cell death, restored renal function, ameliorated kidney damage, improved regenerative potential of renal tubules, and decreased ischemia/reperfusion-induced apoptosis. Although further studies including clinical trials are required in this regard, our findings suggest a novel therapeutic strategy for treatment of AKI. Improved quality of life of patients suffering from renal failure and decreased morbidity and mortality rates would be the potential advantages of this therapeutic strategy., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF